Monthly Archives: October 2010

Then and Now – An Interview with Dr. David Kessler, Former FDA Commissioner, Part 4

In this, the final installment of a 4-part interview with Dr. David Kessler, we departed from our discussion about the past and the present to talk a bit about the future.  For some time, two developments that have often captured … Continue reading

Posted in Uncategorized | 1 Comment

Then and Now – An Interview with Dr. David Kessler, Former FDA Commissioner, Part 3

When Dr. Kessler was the Commissioner of the Food and Drug Administration from 1990-1997, approval times for new drugs were lengthy and people wanted faster approval times and easier access to new medicines.  This was particularly true given the fact … Continue reading

Posted in Uncategorized | Comments Off on Then and Now – An Interview with Dr. David Kessler, Former FDA Commissioner, Part 3

Then and Now – An Interview with Dr. David Kessler, Former FDA Commissioner, Part 2

Recently I had the pleasure of sitting down at length with Dr. David Kessler to discuss some of the challenges in the current regulatory environment.  In general, throughout the discussion, we talked about how things had changed since his time … Continue reading

Posted in Uncategorized | Comments Off on Then and Now – An Interview with Dr. David Kessler, Former FDA Commissioner, Part 2

Then and Now – An Interview with Dr. David Kessler, Former FDA Commissioner

Dr. David Kessler was Commissioner of the Food and Drug Administration from 1990-1997, originally appointed by the first President Bush and re-appointed by President Bill Clinton.  To be appointed by two presidents of different parties is no small feat in … Continue reading

Posted in Uncategorized | Comments Off on Then and Now – An Interview with Dr. David Kessler, Former FDA Commissioner

Weekly Roundup – 10/08/10

It has been a busy week with a dose of travel thrown in for good measure.  The temperature change over the last 10 days has been welcome and remarkable.  Some rain fell in biblical quantities.  And many in Congress have … Continue reading

Posted in Uncategorized | 1 Comment